Corline Biomedical AB (STO:CLBIO)

Corline Biomedical AB Revenue

Corline Biomedical AB had revenue of 1.60M SEK in the quarter ending September 30, 2025, a decrease of -41.55%. This brings the company's revenue in the last twelve months to 8.88M, down -62.28% year-over-year. In the year 2024, Corline Biomedical AB had annual revenue of 17.27M, down -51.37%.

• Revenue (ttm): 8.88M
• Revenue Growth: -62.28%
• P/S Ratio: 42.94
• Revenue / Employee: 683.38K
• Employees: 13
• Market Cap: 381.46M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	17.27M	-18.25M	-51.37%
Dec 31, 2023	35.52M	2.93M	8.98%
Dec 31, 2022	32.59M	15.40M	89.55%
Dec 31, 2021	17.19M	2.12M	14.05%
Dec 31, 2020	15.08M	3.15M	26.44%